Cancer Care

 

 
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients with a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Principal Investigator (?)
Study Number
G237
Summary
This clinical trial is studying biomarkers in diagnosing cervical lesions in patients with
abnormal cervical cells. Studying biomarkers in abnormal cervical cells may improve the
ability to find cervical lesions and plan effective treatment.
Phase (?)
N/A
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.